Fmr LLC Cytokinetics Inc Transaction History
Fmr LLC
- $1.68 Trillion
- Q2 2025
A detailed history of Fmr LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Fmr LLC holds 11,267,511 shares of CYTK stock, worth $688 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
11,267,511
Previous 10,316,131
9.22%
Holding current value
$688 Million
Previous $415 Million
10.21%
% of portfolio
0.02%
Previous 0.03%
Shares
17 transactions
Others Institutions Holding CYTK
# of Institutions
373Shares Held
129MCall Options Held
3.62MPut Options Held
1.14M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$1.07 Billion0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$895 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$731 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$478 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$389 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.75B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...